Alogliptin Impurity 13
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

865758-98-1Alogliptin Impurity 13

● In Stock

Catalogue No.:VL5900007
CAS No.:865758-98-1
Mol. Formula:C17H19N5O2
Mol. Weight:325.37 g/mol

Additional information on CAS 865758-98-1

Parent drug

Alogliptin

IUPAC Name

(R)-2-((6-(3-aminopiperidin-1-yl)-2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile

Synonyms

N/A

Description

Alogliptin Impurity 13 (CAS No: 865758-98-1) or (R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, Alogliptin Impurity 13 is n impurity of Alogliptin, it is a selective, dipeptidyl peptidase-4 inhibitor that is used to treat hyperglycemia in patients with type 2 diabetes mellitus.

References

Kaku, Kohei, et al. “Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus.” Drug Safety, vol. 42, no. 11, 25 Oct. 2019, pp. 1311–1327, 10.1007/s40264-019-00857-8. Accessed 1 May 2020.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url